Most recent update: Wednesday, February 20, 2019 - 16:37
You are here
%2 News
14/02/19 -
Research
Patient experiences
A PhD student at Swansea University has begun a study that is exploring patient experiences during their journey through bariatric surgery. Specifically, looking at the patients’ responses to...
14/02/19 -
Research
EndoBarrier Pivotal Trial
GI Dynamics has received Institutional Review Board (IRB) approval to conduct its pivotal trial of EndoBarrier for type 2 diabetes and obesity. The pivotal trial of EndoBarrier, referred to as the 18...
13/02/19 -
Research
Oestrogen and T2DM
The results of a Texas A&M University-led study provide insights into the mechanism by which oestrogen can decrease insulin resistance and the production of glucose, reducing incidences of Type 2...
13/02/19 -
Event
Meeting preview
On behalf of the executive council of the IFSO Middle East North Africa Chapter (MENAC) it is my honor, privilege and great pleasure to invite you to the 1st IFSO MENAC congress to be held in Kuwait-...
12/02/19 -
Industry
Product launch
Novo Nordisk UK has announced that Ozempic (semaglutide), a once-weekly GLP-1 analogue injection1 for the treatment of type 2 diabetes is now available in the UK. According to the company, Ozempic...
- 1 of 508
- next ›
20/02/19 -
Research
Obesity and genes
A child's risk of obesity as they grow up can be influenced by modifications to their DNA prior to birth, a new University of Southampton study has shown. These changes, known as epigenetic...
19/02/19 -
Research
Lypla1 gene
Susceptibility to obesity, insulin resistance and other cardio-metabolic traits may also be dependent on a person's sex. An international research team of the University of California (UCLA),...
19/02/19 -
Research
High-protein, low-calorie diet
Geriatricians have long struggled with how to recommend safe weight loss for seniors, because dropping pounds can lead to muscle and bone loss. However, a high-protein, low-calorie diet helps older...
